Skip Navigation LinksCAIR-updates-Releases

Top Menu

CALIFORNIA IMMUNIZATION REGISTRY

CAIR Software Releases Notes​

This page communicates the major new features and changes in the California Immunization Registry.

About the Releases

These releases incorporate the correction of some minor defects discovered during the CAIR Implementation contract period and minor enhancements to the California Immunization Registry software.

Compatible Products

This product has been tested on the following platforms or with the following products: CAIR UAT, CAIR TRN, CAIR ONB, CAIR Staging, CAIR Production.​​

December 8, 2025 Release Notes 2.8.34 
November 12, 2025 Release Notes ​2.8.33

October 15, 2025 Release Notes 2.8.31​

September 17, 2025 Release Notes 2.8.31

August 20, 2025 Release 2.8.30​

July 23, 2025 Release 2.8.29

June 25, 2025 Release 2.8.28​

June 4, 2025 Release 2.8.27​

May 7, 2025 Release 2.8.26

April 9, 2025 Release 2.8.25

March 12, 2025 Release 2.8.24

February 13, 2025 Release 2.8.23​

January 21, 2025 Release 2.8.22

December 18, 2024 Release 2.8.21

November 21, 2024 Release 2.8.20

November 4, 2024 Release 2.8.19

September 25, 2024 Off Cycle Release

September 18, 2024 (Release 2.8.18)

August 21, 2024 (Release 2.8.17)

July 24, 2024 (Release 2.8.16)

June 2, 2024 (Release 2.8.14)

June 13, 2023 (Release 3.8.3.11)

April 12, 2023 (Release 3.8.3.9)​

​December 8, 2025 Releas​e 2.8.34

​User Interface​

  1. Updated CAIR Power User Title

    Changed the title of CAIR Power User” to “CAIR Vaccine Inventory User” and “School Clinic Power User” to “School Vaccine Inventory User” in CAIR to better clarify what this role is used for. Corresponding updates to other CAIR systems (e.g. Account Update, Training Registration, etc.) will be applied shortly thereafter.​

​​​

​November 12, 2025 Releas​e 2.8.33​

User Interface and Data Exchange​

  1. Updated Flublok Trivalent PF Influenza-Seasonal schedule

    • ​Updated minimum age to 9 years

  2. Added Moderna mNEXSPIKE to COVID-Seasonal schedule

    • Minimum age of 12 years​

October 15, 2025 Release 2.8.31​​

​User Interface and Data Exchange

  1. Added New NDCs​

TradenameCV​X
NDCPackaging Description
Moderna mNEXSPIKE33480777-0400-60CARTON, 10 PRE-FILLED 0.2 mL SYRINGES
Moderna mNEXSPIKE33480777-0400-61CARTON, 2 PRE-FILLED 0.2 mL SYRINGES
Moderna mNEXSPIKE33480777-0400-62CARTON, 1 PRE-FILLED 0.2 mL SYRINGES
Moderna mNEXSPIKE33480777-0400-17SYRINGE, PRE-FILLED, 10 mcg/0.2 mL
Novavax NUVAXOVID31380631-0207-10CARTON, 10 PRE-FILLED 0.5 mL SYRINGES
Novavax NUVAXOVID31380631-0207-01SYRINGE, PRE-FILLED, 5 mcg/0.5 mL
Pfizer Comirnaty 12Y+30900069-2528-10CARTON, 10 PRE-FILLED 0.3 mL GLASS SYRINGES
Pfizer Comirnaty 12Y+30900069-2528-01SYRINGE, PRE-FILLED, GLASS, 30 mcg/0.3 mL
Pfizer Comirnaty (Blue Cap) 5Y-11Y31000069-2501-10CARTON, 10 SINGLE-DOSE 0.3 mL VIALS
Pfizer Comirnaty (Blue Cap) 5Y-11Y31000069-2501-01VIAL, SINGLE-DOSE, 10 mcg/0.3 mL
Moderna Spikevax 12+31280777-0112-96CARTON, 10 PRE-FILLED 0.5 mL SYRINGES
Moderna Spikevax 12+31280777-0112-93CARTON (Blister Pack), 10 PRE-FILLED 0.5 mL SYRINGES
Moderna Spikevax 12+31280777-0112-88CARTON, 2 PRE-FILLED 0.5 mL SYRINGES
Moderna Spikevax 12+31280777-0112-01SYRINGE, PRE-FILLED, 50 mcg/0.5 mL
Moderna Spikevax 6M-11Y31180777-0113-80CARTON, 10 PRE-FILLED 0.25 mL SYRINGES
Moderna Spikevax 6M-11Y31180777-0113-87CARTON, 2 PRE-FILLED 0.25 mL SYRINGES
Moderna Spikevax 6M-11Y31180777-0113-09SYRINGE, PRE-FILLED, 25 mcg/0.25 mL
PEDIARIX11050090-7541-0010  .5mL SYRINGE in 1 CARTON
PEDIARIX11050090-7541-01.5 mL in 1 SYRINGE


Inactivated/Retired NDCs

Tradename​
NDC
Pfizer Bivalent 12+59267-0304-01
Pfizer Bivalent 12+59267-1404-01
Pfizer Bivalent 5-11Y59267-0565-01
Pfizer Bivalent 6M-4Y59267-0609-01
Pfizer Comirnaty (Gray Cap) 12Y+00069-2025-01
Pfizer COVID (Maroon Cap) <5Y59267-0078-01
Pfizer BioNTech 6M-4Y59267-4426-02
Pfizer BioNTech 6M-4Y59267-4426-01
Pfizer BioNTech (Blue Cap) 5Y-11Y59267-4438-02
Pfizer BioNTech (Blue Cap) 5Y-11Y59267-4438-01
Moderna Bivalent 6M+80777-0282-05
Moderna Bivalent 6M-5Y80777-0283-02
Moderna Spikevax (Red Cap) 12Y+80777-0100-11
Moderna Spikevax (Red Cap) 12Y+80777-0273-10
Spikevax Moderna COV2 12+80777-0110-01
Spikevax Moderna COV2 12+80777-0110-93
Spikevax Moderna COV2 12+80777-0110-96
Moderna COV2 6M-11Y80777-0291-80
Moderna COV2 6M-11Y80777-0291-09
Novavax COV2 12+80631-0107-01
Novavax COV2 12+80631-0107-10
SHINGRIX58160-0819-12
SHINGRIX58160-0828-01


2. Added vaccines to the dropdown list in the Enter Historical Immunization screen. 

Vaccine Na​​me
CVX
DTAP/IPV/HIB Non-US170
OPV, Bivalent Non-US178
OPV, Monovalent Non-US179
OPV Unspecified182
Fractional dose FIPV NOS Non-US324​

​User Interface

3. Fixed issue with the State Supplied Flu Report. 

  • Previously, the State Supplied Flu Report only displayed doses administered using lots from CAIR Inventory. 
  • The State Supplied Flu Report will capture and display all administered flu doses with the following funding eligibility codes: VFC, 317 and State General Fund. 


September 17, 2025 Release 2.8.31

User Interface and Data Exchange

  1. ​Updated RSV Infant Enflonsia schedule
    • Added Clesrovimab/Enflonsia as an acceptable vaccine
    • Set Max age of 8 months

  2. ​​Added New NDCs

Tradena​me
ManufacturerNDCPackaging Description
Fluarix Trivalent PFSKB58160-0912-5210 SYRINGE in 1 CARTON
Fluarix Trivalent PFSKB58160-0912-41.5mL in 1 SYRINGE
Flublok Trivalent PFPMC49281-0725-1010 SYRINGE in 1 CARTON
Flublok Trivalent PFPMC49281-0725-88.5mL in 1 SYRINGE
FluMist TrivalentMED66019-0112-1010 APPLICATOR in 1 CARTON
Flumist TrivalentMED66019-0112-00.2mL in 1 APPLICATOR
ShingrixSKB58160-0849-5210 SYRINGE in 1 CARTON
ShingrixSKB58160-0849-43.5mL in 1 SYRINGE

         

 Reactivated NDCs

TradenameManufacturerNDCPackaging Description
Pfizer BioNTech ​(Blue cap) 5Y-11Y
PFR59267-4438-01.48 mL in 1 VIAL,SINGLE-DOSE
Pfizer BioNTech (Blue cap) 5Y-11YPFR59267-4438-0210 VIAL,SINGLE-DOSE in 1 CARTON
Pfizer BioNTech 6M-4YPFR59267-4426-011.58 mL in 1 VIAL, MULTI-DOSE
Pfizer BioNTech 6M-4YPFR59267-4426-0210 VIAL, MUTI-DOSE in 1 CARTON

 

 Inactivated/Retired NDCs

Tradename​​
NDC
Vivotif69401-0000-01
Vivotif69401-0000-02
Cholera-O70460-0002-02
Vaxchora70460-0004-01
Stamaril49281-0913-01
Flumist Quadrivalent66019-0311-00
Flumist Quadrivalent66019-0311-10
Flublok Quadrivalent49281-0722-10
Flublok Quadrivalent49281-0722-88

 

User Interface

  1. ​​​​​​​​​​Fixed issue with Add Patient screen
    • ​​​​​​​​​The Add Patient Screen will not remove information if one or more required fields are left blank. This will allow users to make corrections without reentering patient's information.
  1. ​​Fixed issue with the “Update" button on the Duplicate Immunizations Found screen

    • ​​​​When CAIR2 notices a possible duplicate dose, the Duplicate Immunizations Found screen will display. If the user selects “Update", the dose will deduct from CAIR Inventory twice. The fixes will correct the incorrect deduction and will only deduct from CAIR Inventory once. ​


    ​​


    August 20, 2025 Release 2.8.30

    ​User Interface and Data Exch​​ange 

    1. Updated Bexsero Series

      • ​​​Added Penmenvy as an acceptable vaccine

      • Set Max age to 26Y

    2. ​​​​Updated Hep B series

      • ​​​​​​Added Heplisav-B as an acceptable vaccine

    3. ​​​Added New NDCs for Influenza-Seasonal vaccines 

      Tra​den​ame
      		 Manufacturer NDC Packaging Description
      Afluria Trivalent Preservative​

      		 SEQ 33332-0125-10 1 VIAL, MULTI-DOSE IN 1 CARTON
      Afluria Trivalent Preservative SEQ 33332-0125-11 5 ML IN 1 VIAL, MULTI-DOSE
      Afluria Trivalent PF SEQ 33332-0025-03 10 SYRINGE, GLASS IN 1 CARTON
      Afluria Trivalent PF SEQ 33332-0025-04 .5 ML IN 1 SYRINGE, GLASS
      Fluad Trivalent PF SEQ 70461-0025-03 10 SYRINGE, GLASS IN 1 CARTON
      Fluad Trivalent PF SEQ 70461-0025-04 .5 ML IN 1 SYRINGE, GLASS
      Flucelvax Trivalent PF SEQ 70461-0655-03 10 SYRINGE, GLASS IN 1 CARTON
      Flucelvax Trivalent PF SEQ 70461-0655-04 .5 ML IN 1 SYRINGE, GLASS
      Flucelvax Trivalent Preservative SEQ 70461-0555-10 1 VIAL, MULTI-DOSE IN 1 CARTON
      Flucelvax Trivalent Preservative SEQ 70461-0555-11 5 ML IN 1 VIAL, MULTI-DOSE
      Flulaval Trivalent PF IDB 19515-0904-41 .5 ML IN 1 SYRINGE
      Flulaval Trivalent PF IDB 19515-0904-52 10 SYRINGE IN 1 CARTON
      Fluzone High-Dose Trivalent PF PMC 49281-0125-65 5 SYRINGE, GLASS IN 1 PACKAGE
      Fluzone High-Dose Trivalent PF PMC 49281-0125-88 .5 ML IN 1 SYRINGE, GLASS
      Fluzone Trivalent Preservative PMC 49281-0643-15 1 VIAL, MULTI-DOSE IN 1 PACKAGE
      Fluzone Trivalent Preservative PMC 49281-0643-78 5 ML IN 1 VIAL, MULTI-DOSE
      Fluzone Trivalent PF PMC 49281-0425-50 10 SYRINGE, GLASS IN 1 PACKAGE
      Fluzone Trivalent PF PMC 49281-0425-88 .5 ML IN 1 SYRINGE, GLASS​

    4. Added New NDCs for RSV vaccines
    Tradename Manufacturer NDC Packaging Description
    ENFLONS​IA
    		 MSD 00006-5073-01 CARTON, 1 SYRINGE, GLASS
    ENFLONSIA MSD 00006-5073-02 CARTON, 10 SYRINGE, GLASS
    ENFLONSIA MSD 00006-5073-99 SYRINGE, 0.7 mL
    mRESVIA MOD 80777-0345-61 10 SYRINGE IN 1 CARTON
    mRESVIA MOD 80777-0345-62 1 SYRINGE IN 1 CARTON
    mRESVIA MOD 80777-0345-63 2 SYRINGE IN 1 CARTON​

    Data Exchange 

    5. ORC-12 and RXA-10

      • ​​​​​​​​Corrected a parsing bug in the ORC-12 and RXA-10 fields of a VXU that ignores an invalid value or empty field when sent in the ORC-12 or RXA-10 name fields and does not return a complete error response in the ACK.​


    July 23, 2025 Release 2.8.29

    User Interface and Data Exchange

    1. Updated Max Age for HPV Adult schedule
      • Set Max Age to 46Y
    2. Updated Meningococcal schedule
      • Added Trumenba as an acceptable vaccine to Penbraya series
      • Added Penbraya as an acceptable vaccine to Trumenba series
      • Added Bexsero as an acceptable vaccine to Penmenvy series
    3. Added new vaccines and CVX codes

    ​​Vaccine

    ​Vaccine Name

    ​CVX

    Influenza-Seasonal

    ​Fluzone Trivalent Southern Hemisphere

    ​331

    ​Dengue

    ​Dengue fever unspecified NOS (Default)

    ​330

    ​Orthopox

    ​Vaccinia smallpox mpox unspecified NOS (Default)

    ​325​
    1. Added new NDCs for Adeno T4 and T7
    ​Tradename
    		 ​Manufacturer
    		 ​NDC
    		 ​Packaging Description
    ​Adeno T4 and T7
    		 ​TEVA Pharmaceuticals
    		 ​51285-0138-50
    		 ​1 KIT in 1 CARTON
    ​Adeno T4 and T7
    		 ​TEVA Pharmaceuticals
    		 ​51285-0175-02
    		 ​100 TABLET, COATED in 1 BOTTLE
    ​Adeno T4 and T7
    		 ​TEVA Pharmaceuticals
    		 ​51285-0174-02​
    		 ​100 TABLET, COATED in 1 BOTTLE

    ​User Interface
    1. Fixed issue with VIS Date not displaying on the Enter New Immunization screen.

      • ​​​VIS Date will display after Tradename is selected. ​

    Data Exchange

    1. Updated our query response messages (RSP) to better conform to the CDC HL7 2.5.1 VXU Implementation Guide for Immunization Messaging. As of June 25, 2025 this RSP update has been held in the CAIR testing environment (ONB) so that our DX partners can test the updates against their systems prior to releasing into PROD. Separate communications containing details of the CAIR Query Response Message (RSP) Segment and Field updates were sent out on July 7, 2025 and June 20, 2025.

    2. Updated new race logic for incoming data that includes a new race to be added. Any existing races that are not included in the incoming HL7 VXU messages, flat files or vital record uploads will remain visible (not hidden) when adding the incoming race.

    3. Updated the hide race flags to hide the race Prefer Not to Say (PHC1175) when incoming data from HL7 VXU messages and vital record uploads include a new race to be added.

    4. Added County, State and Country of birth to the pending table when a Vitals Birth Record is uploaded and becomes a pending record. Followed by updating the pending flow process to load the sharing and the disclosure fields per specifications, set the mother’s address as the patient’s address, capture the mother’s maiden name and the father’s first and last name.

    5. Updated the RXA evaluation code to return the appropriate message when RXA-6 contains alpha characters and RXA-5 does not contain the NDC in the first triplet (RXA-5.1).​

    June 25, 2025 Release 2.8.28​

    User Interface and Data Exchange

    1. Updated Chikungunya Adult schedule
      1. For the IXCHIQ vaccine, min age 18y and max age 60y
      2. For the VIMKUNYA vaccine, min age 12y
    2. Updated PCV Child schedule
      1. Added max age of 5y
      2. Recommendation table will display Maximum Age Exceeded for patients over 5y and have not completed PCV child series

    User Interface

    1. Removed NOS Tradename from the Immunization History Report and Immunizations Needed/Routing Slip Report.

    Data Exchange

    1. Updated the ERR-8 description on four CAIR ACKs to provide better detail on the warning or informational message returned.
    2. Updated our query response messages (RSP) to better conform to the CDC HL7 2.5.1 VXU Implementation Guide for Immunization Messaging.  This RSP update will be held in the CAIR testing environment (ONB) so that our DX partners can test the updates against their systems.  The RSP update will then be released into PROD with Sprint 27 (anticipated PROD release date is July 23, 2025).  Details of the RSP updates will follow in a separate communication.​

    ​

    June 4, 2025 Release 2.8.27

    User Interface

    1. Added Org Code to Dose Administered Report

      • Updated the Filter's title to Organization Name.

      • Added Organization Code title to display provider's Org Code on the report.

    2. Updated Tradename list to sort in alphabetical order

      • Under Enter New Immunization screen, Tradenames will display list in alphabetical order.

    User Interface and Data Exchange

    1. Updated COVID Seasonal Schedule

      • Updated schedule for patients under age 65.

      • Updated schedule for patients over age 65.

    2. Valid doses of COVID Seasonal immunization will display as “Dose” in CAIR.

    3. Added PENMENVY schedule

      • 2 dose series.

      • Minimum age 10y and maximum age 26y to validate.

      • If a patient receives one dose and has not completed series before age 26, CAIR Recommendation Table will no longer recommend and will display Maximum Age Exceeded for series.

    4. Removed NDC End Dates

      • Dose will no longer display as Not Valid with Explanation of Status stating, “Dose was given after NDC end date.”


    May 7, 2025 Release 2.8.26

    ​User Interface and Data Exchange 

    1. Added CDPH branding to CAIR2 website favicon
    2. Updated Release Notes link
      1. The link will open in a new browser window and take CAIR2 users to the CDPH website site where all CAIR2 Release Notes are posted.
    3. Updated Trumenba schedule
      1. Updated recommendation interval to 6m between dose 1 and dose 2
    4. Updated MenACWY schedule
      1. Updated minimum age to 11Y
      2. If the initial dose is administered at 16Y+, no additional booster is needed
    5. Added new Tradenames, CVX codes, and NDCs
    Vaccine​​ Tradename NDC Packaging Description CVX
    Chikungunya VIMKUNYA 50632-0018-02 1 SYRINGE, GLASS IN 1 CARTON  329
    Chikungunya VIMKUNYA 50632-0018-04 .8 ML in 1 SYRINGE, GLASS 329
    Meningococcal PENMENVY 58160-0757-15 1 KIT in 1 CARTON 328
    Meningococcal PENMENVY 58160-0730-03 .5 mL in 1 VIAL 328
    Meningococcal PENMENVY
    		 58160-0750-03 .5 mL in 1 SYRINGE 328

     

    Data Exchange

    1. Added validation of the RXA-6 field (administered amount) and RXA-7 field (unit of measurement) in the VXU message.
    2. Valid matched administered amount and unit of measurement will be returned in a query response file.
      1. If there is no dose match, RXA-6 will contain “999” (unknown dose amount).
      2. If immunization returned is historical, “999” will be returned. 

    ​

    April 9, 2025 Release 2.8.25

    User Interface and Data Exchange

    1. Updated CDPH branding on the Yellow card and Blue card
    2. Updated Hep B Schedule
      1. Applied “Atkinson Rule” to Hep B Pediatric and Adult series
      2. Atkinson Rule states the series should not exceed 4 doses
    3. Fixed issue with PCV10
      1. When providers add the PCV10 vaccine to patient's record, the immunization was displaying twice. Issue has been fixed and duplicate doses for PCV10 will be removed.
    4. Added new NDCs for MMR II, HyperRAB and Shingrix
    V​a​ccine​​ Tradename NDC Packaging Description
    MMR MMR II 50090-1860-00 10 VIAL, SINGLE-DOSE IN 1 CARTON
    MMR MMR II​

    		 50090-1860-09 .5 ML IN 1 VIAL, SINGLE-DOSE
    RIg HyperRAB 13533-0318-05 1 VIAL IN 1 CARTON
    RIg HyperRAB 13533-0318-50 5 ML IN 1 VIAL
    Zoster Shingrix 50090-3372-00 1 KIT IN 1 KIT

    ​ 

    March 12, 2025 Release 2.8.24

    User Interface and Data Exchange​

    1.       Updated PCV13 Adult Schedule
    a.       Added PCV21 as an acceptable vaccine
    b.       Updated recommendation to 50 years

    2.       Added PCV13 PPSV23 Adult Schedule
    a.       Added recommendation of 50 years
    b.       Added min age to validate of 19 years

    *Notes on PCV13 PPSV23 Adult schedule
    If a patient receives PPSV23 as a second dose before age 65, dose 3 is required to complete series.

    3.       Updated Bexsero Schedule
    a.       Updated recommendation interval from 28D to 6M

    *Notes on Bexsero schedule
    For high-risk patients, CAIR2 will validate doses entered but the recommendation table will follow ACIP recommendation.

    4.       Frequent logouts mid-session in CAIR2
    a.       Issue with unexpected logouts mid-sessi​on is fixed. Users should not experience unexpected logouts while navigating through CAIR2 application. ​

    ​

    February 13, 2025 Release 2.8.23

    User Interface

    1. Updated new CDPH branding in CAIR2. Added new footer with CDPH branding and updated header banner and left sidebar colors.
    2. “Current Dose” displayed in the Edit Vaccine Inventory Information screen. When vaccines in CAIR inventory have a dose amount stored that is not a valid value, the Select Dose will display blank. The “Current Dose” will display the amount that was last recorded for the vaccine. Once the Select Dose is updated, the same value will display in Select Dose and Current Dose.
    3. Fixed bug within the Org Extract report. The fixes will allow users to download the outbound files.

    User Interface and Data Exchange

    1. Removed vaccines with NOS from the Trade Name dropdown on the Enter New Immunization screen. These vaccines will be available on the Add Historical Immunizations screen.
      1. Tradenames moved to Historical Imms only: Tdap > 7 years, NOS, MenC, NOS and OPV Polio Oral, NOS. 

    January 21, 2025 Release 2.8.22

    ​

    User Interface and Data Exchange

    1. ​Updated PCV21 Schedule (One dose series)
      • ​​Set recommendation age to 50 years.
      • Update minimum age allowed to 19 years.
    PCV15, PCV21 and PPSV23 Adult series updated recommendation to 50 years. 

    2. Updated Dose Amount values

    In the Add Vaccine Inventory Information and Edit Vaccine Inventory Information screen, the Dose Amount list has been updated and will only display the following dose amounts:
    0.20
    0.25
    0.30
    0.50
    0.65
    0.70
    1.00
    1.50
    1.58
    2.0
    2.25
    2.50
     
    3. Added column on the Edit Vaccine Inventory Information screen to display the user role of the person updating the CAIR Inventory.
      • ​​​​​​​Merge Staff user role will display when duplicate records are found and patient is merged by CDPH staff.​

    December 18, 2024 Release 2.8.21

    User Interface

    1. “Activate Expired” button on the Enter New Immunization screen fixed.

    Under the Add New Immunization screen, users could add immunizations using expired vaccines from their inventory. The “Activate Expired” button will display expired vaccines in the Tradename dropdown.

    User Interface and Data Exchange

    1. Updated RSV Adult Schedule

    Set recommended age to 75 years

    • Set Invoke on age to 60 years

    Update the Minimum age allowed:

    • Arexvy Vaccine
      • High-risk individuals 50-59 years of age.
    • Abrysvo Vaccine
      • High-risk individuals 18-59 years of age.
      • Females ages 15-50 will fall into the pregnancy schedule. 
    1. Added CVX and NDC code to Edit Immunization Screen​

    November 21, 2024 Release 2.8.20

    ​​​User Interface and Data Exchange

    ​1. Added NOS/Unspecified Tradenames to CAIR under the Enter Historical Immunization Details screen. 

    Tradename CVX
    HepA, NOS​
    		 85
    VEE unspecified formulation 92
    MenC, NOS 103
    DTaP, NOS 107
    Tdap > 7 years, NOS 115
    HPV NOS 137
    MCV4, NOS 147
    Rho(D) unspecified formulation 159
    Zoster, NOS 188
    Td adsorbed pf adult Lf NOS 196
    Ebola unspecified 214
    Tick-borne encephalitis unspecified 222
    RSV unspecified 304
    RSV vaccine unspecified 314
    RSV monoclonal antibody (MAB) NOS 315
    HepB NOS 45
    MENINGOVAX-AC NOS 108
    OPV Polio Oral NOS 02
    Influenza NOS 88
    DTaP-IPV-Hib-HepB Historical 132

     

    2. Removed “Parent Recall” from Source of Imm list under Enter Historical Immunization Details screen. 

    3. Added new NDC code for Vaxchora. ​

    Tradename NDC code 11 digit Description CVX
    Vaxchora 50632-0015-02 1 Kit in 1 Carton 174

     
    4. Added new Dose sizes 4.0 and 100 to Add Vaccine Inventory Information and Edit Vaccine Inventory Information screens. 

    November 4, 2024 Release 2.8.19

    User Interface

    1. PPSV23 issue in children under 5-years-old

    ​​Issue found in patients who received the Pneumococcal 23 (PPSV23) vaccine as a first dose in PCV series and received the MMR (combo) vaccine. The MMR combo vaccine prevents the PCV immunization from displaying on patients’ records. The fix will allow all doses to display correctly on patients’ records.

     

    Data Exchange​

    1. For VXU messages:  Updated the RXA-6 and RXA-7.1 field validation in CAIR2.

    ​RXA-6 (Dose Amount) and RXA-7.1 (Unit of Measure) values sent in an HL7 VXU message will be accepted and stored in the CAIR database tables if the fields meet CAIR validation rules. 

     

    RXA-6 will be required for all given immunizations (RXA-9.1 equals “00”). When the RXA-6 field is null, “0” (zero), or contains alpha characters and the RXA-9.1= “00,” a warning ACK will be returned to the message submitter. The RXA segment will be accepted, but the dose amount will default to “Full Dose” in CAIR (value = ‘1’ being the default dose number).

     

    EXAMPLE ACK WHEN RXA-6 IS “0” or null:

    ERR||RXA^1^6|102^Data Type Error^HL70357^101^Required Field Missing^HL70357|W|4^Invalid value^HL70533|||Warning: RXA-6 Administered amount must have a numeric value greater than “0.” Correction Requested

     

    ​The following values will be accepted in RXA-7.1 of the VXU: mL (e.g. milliliter), mg (e.g. milligram), and mcg (e.g. microgram). If RXA-7.1 contains any value other than the three values listed above, the unit of measure will default to ‘mL.’ The field is not case sensitive.


    September 25, 2024 Off Cycle Release​

    User Interface and Data Exchange Users

    COVID Vaccines for the 2024-2025 Season

    Added new COVID Seasonal NDCs. CAIR users will be able to add new COVID Seasonal vaccines to CAIR Inventory and record administered doses to patients’ records.

    Tradena​​me NDC Code 11 digit NDC Code 10 Digit Description CVX CPT MVX
    Pfizer Comirnaty 12Y+ 00069-2432-10 0069-2432-10 10 SYRINGE, GLASS in 1 CARTON 309 91320 PFR
    Pfizer Comirnaty 12Y+ 00069-2432-01 0069-2432-01 .418 mL in 1 SYRINGE, GLASS 309 91320 PFR
    Pfizer BioNTech (Blue Cap) 5Y-11Y 59267-4438-02 59267-4438-2 10 VIAL, SINGLE-DOSE in 1 CARTON 310 91319 PFR
    Pfizer BioNTech (Blue Cap) 5Y-11Y 59267-4438-01 59267-4438-1 .48 mL in 1 VIAL, SINGLE-DOSE 310 91319 PFR
    Pfizer BioNTech 6M-4Y 59267-4426-02 59267-4426-2 10 VIAL, MULTI-DOSE in 1 CARTON 308 91318 PFR
    Pfizer BioNTech 6M-4Y 59267-4426-01 59267-4426-1 1.58 mL in 1 VIAL, MULTI-DOSE 308 91318 PFR
    Spikevax Moderna COV2 12+ 80777-0110-96 80777-110-96 10 SYRINGE, PLASTIC in 1 CARTON 312 91322 MOD
    Spikevax Moderna COV2 12+ 80777-0110-01 80777-110-01  .5 mL in 1 SYRINGE, PLASTIC 312 91322 MOD
    Spikevax Moderna COV2 12+ 80777-0110-93 80777-110-93 10 SYRINGE, PLASTIC in 1 CARTON 312 91322 MOD
    Moderna COV2 6M-11Y 80777-0291-80 80777-291-80 10 SYRINGE, PLASTIC in 1 CARTON 311 91321 MOD
    Moderna COV2 6M-11Y 80777-0291-09 80777-291-09  .25 mL in 1 SYRINGE, PLASTIC 311 91321 MOD
    Moderna COV2 6M-11Y 80777-0291-81 80777-291-81 10 SYRINGE, PLASTIC in 1 CARTON 311 91321 MOD
    Novavax COV2 12+ 80631-0107-10 80631-107-10 10 SYRINGE, GLASS in 1 CARTON 313 91304 NVX
    Novavax COV2 12+ 80631-0107-01 80631-107-01  .5 mL in 1 SYRINGE, GLASS 313 91304 NVX

     

    Added End Dates to COVID NDCs.

    For User Interface, any vaccines from inventory with the following NDCs will display as “Not Valid” and the Explanation of Status will indicate “Dose was given after NDC end date” when immunizations are recorded after End Date.

    For Data Exchange, when users select the NDCs listed below, immunizations recorded after the End Date will display as “Not Valid” and the Explanation of Status will indicate “Dose was given after NDC end date.”

    Tradename NDC Code 11 digit End Date
    Pfizer Comirnaty 12Y+ 00069-2377-10 8/21/2024
    Pfizer Comirnaty 12Y+ 00069-2377-01 8/21/2024
    Pfizer Comirnaty 12Y+​​

    		 00069-2362-10 8/21/2024
    Pfizer Comirnaty 12Y+ 00069-2362-01 8/21/2024
    Pfizer BioNTech (Blue Cap) 5Y-11Y 59267-4331-02 8/31/2024
    Pfizer BioNTech (Blue Cap) 5Y-11Y 59267-4331-01 8/31/2024
    Moderna COV2 6M-11Y 80777-0287-92 8/21/2024
    Moderna COV2 6M-11Y 80777-0287-07 8/21/2024
    Spikevax Moderna COV2 12+ 80777-0102-95 8/21/2024
    Spikevax Moderna COV2 12+ 80777-0102-04 8/21/2024
    Spikevax Moderna COV2 12+ 80777-0102-96 8/21/2024
    Spikevax Moderna COV2 12+ 80777-0102-01 8/21/2024
    Spikevax Moderna COV2 12+ 80777-0102-93 8/21/2024
    Spikevax Moderna COV2 12+ 80777-0102-01 8/21/2024

     

    FluMist Trivalent

    Added FluMist Trivalent NDCs. CAIR users will be able to add FluMist Trivalent to CAIR Inventory and record administered doses to patients’ records.

    Tradenam​​e NDC Code 11 digit NDC Code 10 Digit Description CVX CPT MVX
    FluMist Trivalent 66019-0311-10 66019-311-10 10 APPLICATOR in 1 PACKAGE 111 90660 MED
    FluMist Trivalent 66019-0311-00 66019-311-00  .2 mL in 1 APPLICATOR 111 90660 MED

     

    Added End Dates to FluMist Quadrivalent NDCs.

    For User Interface, any vaccines from inventory with the following NDCs will display as “Not Valid” and the Explanation of Status will indicate “Dose was given after NDC end date”​ when immunizations are recorded after End Date.

    For Data Exchange, when users select the NDCs listed below, immunizations recorded after the End Date will display as “Not Valid” and the Explanation of Status will indicate “Dose was given after NDC end date.”

    Tradename NDC Code 11 digit End Date
    FluMist Qua​​drivalent
    		 66019-0310-10 8/5/2024
    FluMist Quadrivalent 66019-0310-01 8/5/2024


    September 18, 2024 (Release 2.8.18)

    User Interface and Data Exchange Users

    Trivalent Flu Vaccines for 2024-2025 Season

    1.1 Updated Vaccine names and added Tradenames for the Influenza Seasonal Group.​

    Vaccine ​​Name

    Trade Name

    CVX

    CPT

    MVX

    (23) Influenza live trivalent intranasal

    FluMist Trivalent

    111

    90660

    MED

    (819) Influenza high-dose trivalent PF

    Fluzone High-Dose Trivalent PF

    135

    90662

    PMC

    (128) Influenza split virus trivalent PF

    Afluria trivalent PF

    140

    90656

    SEQ

    (128) Influenza split virus trivalent PF

    Fluarix trivalent PF

    140

    90656

    SKB

    (128) Influenza split virus trivalent PF

    Flulaval trivalent PF

    140

    90656

    IDB

    (128) Influenza split virus trivalent PF

    Fluzone trivalent PF

    140

    90656

    PMC

    (720) Flu split virus trivalent preservative

    Afluria trivalent preservative

    141

    90657

    SEQ

    (720) Flu split virus trivalent preservative

    Afluria trivalent preservative

    141

    90658

    SEQ

    (720) Flu split virus trivalent preservative

    Fluzone trivalent preservative

    141

    90657

    PMC

    (720) Flu split virus trivalent preservative

    Fluzone trivalent preservative

    141

    90658

    PMC

    (833) Influenza MDCK trivalent PF

    Flucelvax trivalent PF

    153

    90661

    SEQ

    (835) Influenza recombinant trivalent PF

    Flublok trivalent PF

    155

    90673

    PMC

    (845) Influenza adjuvanted trivalent PF

    Fluad trivalent PF

    168

    90653

    SEQ

    1.2 Added new Influenza Seasonal NDCs.​

    Tradena​​me NDC Code 11 digit NDC Code 10 Digit Description CVX CPT MVX

    Fluzone High-Dose Trivalent PF

    49281-0124-65

    49281-124-65

    10 SYRINGE, GLASS in 1 PACKAGE

    135

    90662

    PMC

    Fluzone High-Dose Trivalent PF

    49281-0124-88

    49281-124-88

     .5 mL in 1 SYRINGE, GLASS

    135

    90662

    PMC

    Fluarix trivalent PF

    58160-0884-52

    58160-884-52

    10 SYRINGE in 1 CARTON

    140

    90656

    SKB

    Fluarix trivalent PF

    58160-0884-41

    58160-884-41

    .5 mL in 1 SYRINGE

    140

    90656

    SKB

    Flulaval trivalent PF

    19515-0810-52

    19515-810-52

    10 SYRINGE in 1 CARTON

    140

    90656

    IDB

    Flulaval trivalent PF

    19515-0810-41

    19515-810-41

    .5 mL in 1 SYRINGE

    140

    90656

    IDB

    Fluzone trivalent PF

    49281-0424-50

    49281-424-50

    10 SYRINGE, GLASS in 1 PACKAGE

    140

    90656

    PMC

    Fluzone trivalent PF

    49281-0424-88

    49281-424-88

    .5 mL in 1 SYRINGE, GLASS

    140

    90656

    PMC

    Afluria trivalent PF

    33332-0024-03

    33332-024-03

    10 SYRINGE, GLASS in 1 CARTON

    140

    90656

    SEQ

    Afluria trivalent PF

    33332-0024-04

    33332-024-04

    .5 mL in 1 SYRINGE, GLASS

    140

    90656

    SEQ

    Afluria trivalent preservative

    33332-0124-10

    33332-124-10

    1 VIAL, MULTI-DOSE in 1 CARTON

    141

    90658
    90657

    SEQ

    Afluria trivalent preservative

    33332-0124-11

    33332-124-11

    5 mL in 1 VIAL, MULTI-DOSE

    141

    90658
    90657

    SEQ

    Fluzone trivalent preservative

    49281-0641-15

    49281-641-15

    10 VIAL, SINGLE-DOSE in 1 PACKAGE

    141

    90658
    90657

    PMC

    Fluzone trivalent preservative

    49281-0641-78

    49281-641-78

    .5 mL in 1 VIAL, SINGLE-DOSE

    141

    90658
    90657

    PMC

    Flucelvax trivalent PF

    70461-0654-03

    70461-654-03

    10 SYRINGE, GLASS in 1 CARTON

    153

    90661

    SEQ

    Flucelvax trivalent PF

    70461-0654-04

    70461-654-04

    .5 mL in 1 SYRINGE, GLASS

    153

    90661

    SEQ

    Flublok trivalent PF

    49281-0724-10

    49281-724-10

    10 SYRINGE in 1 CARTON

    155

    90673

    PMC

    Flublok trivalent PF

    49281-0724-88

    49281-724-88

    .5 mL in 1 SYRINGE

    155

    90673

    PMC

    Fluad trivalent PF

    70461-0024-03

    70461-024-03

    10 SYRINGE, GLASS in 1 CARTON

    168

    90653

    SEQ

    Fluad trivalent PF

    70461-0024-04

    70461-024-04

    .5 mL in 1 SYRINGE, GLASS

    168

    90653

    SEQ

    ​

    1.3 Added End Dates to Trivalent Flu NDCs.

    Tradename​

    NDC

    CVX

    End date

    FLUMIST

    66019-0108-01

    111

    6/30/2011

    Fluzone High Dose

    49281-0399-88

    135

    6/30/2017

    AFLURIA Pres Free

    33332-0009-01

    140

    6/30/2024*

    Fluarix Pres-Free

    58160-0879-41

    140

    6/30/2013

    Fluarix Pres-Free

    58160-0881-41

    140

    6/30/2015

    Fluarix Pres-Free

    76420-0471-01

    140

    6/30/2024*

    Fluzone Pres Free

    58160-0877-46

    140

    6/30/2024*

    AFLURIA

    33332-0109-10

    141

    6/30/2024*

    FluLaval

    19515-0887-07

    141

    6/30/2024*

    Fluvirin

    76420-0470-10

    141

    6/30/2024*

    Fluzone

    49281-0009-25

    141

    6/30/2024*

    FLUCELVAX

    70461-0614-01

    153

    6/30/2024*

    FLUCELVAX

    70461-0614-11

    153

    6/30/2024*

    Flublok

    42874-0012-01

    155

    6/30/2013

    Flublok

    42874-0116-01

    155

    6/30/2024*​


    Quadrivalent Flu Vaccines Update

    2.1 Updated the Quadrivalent Flu Vaccine Names.

    Vaccine ID​

    New Vaccine Name

    CVX

    828

    Influenza live quadrivalent intranasal

    149

    830

    Influenza split virus quadrivalent PF

    150

    836

    Influenza split virus quadrivalent Preservative

    158

    847

    Influenza MDCK quadrivalent PF

    171

    859

    Influenza recombinant quadrivalent PF

    185

    858

    Influenza MDCK quadrivalent preservative

    186

    872

    Influenza high-dose quadrivalent PF

    197

    873

    Influenza adjuvanted quadrivalent PF

    205


    2.2 Added End Dates for Quadrivalent Flu Vaccines for the 2023-2024 Season.

    Traden​ame

    NDC Code 11 digit

    NDC Code 10 Digit

    CVX

    Sale End Date

    Afluria Quad Pres-Free

    33332-0323-03

    33332-323-03

    150

    6/30/2024

    Afluria Quad Pres-Free

    33332-0323-04

    33332-323-04

    150

    6/30/2024

    Afluria, quadrivalent

    33332-0423-10

    33332-423-10

    158

    6/30/2024

    Afluria, quadrivalent

    33332-0423-11

    33332-423-11

    158

    6/30/2024

    FLUAD Quadrivalent

    70461-0123-03

    70461-123-03

    205

    6/30/2024

    FLUAD Quadrivalent

    70461-0123-04

    70461-123-04

    205

    6/30/2024

    Fluarix Quadrivalent

    58160-0909-52

    58160-909-52

    150

    6/30/2024

    Fluarix Quadrivalent

    58160-0909-41

    58160-909-41

    150

    6/30/2024

    Flublok Quadrivalent

    49281-0723-10

    49281-723-10

    185

    6/30/2024

    Flublok Quadrivalent

    49281-0723-88

    49281-723-88

    185

    6/30/2024

    Flucelvax Quadrivalent

    70461-0323-03

    70461-323-03

    171

    6/30/2024

    Flucelvax Quadrivalent

    70461-0323-04

    70461-323-04

    171

    6/30/2024

    Flucelvax Quadrivalent

    70461-0200-12

    70461-200-12

    171

    6/30/2024

    Flucelvax Quadrivalent

    70461-0320-03

    70461-0320-3

    171

    7/1/2021

    FLUCELVAX QUAD (MDV)

    70461-0423-10

    70461-423-10

    186

    6/30/2024

    FLUCELVAX QUAD (MDV)

    70461-0423-11

    70461-423-11

    186

    6/30/2024

    FluLaval Quad PF 0.5mL

    19515-0814-52

    19515-814-52

    150

    6/30/2024

    FluLaval Quad PF 0.5mL

    19515-0814-41

    19515-814-41

    150

    6/30/2024

    FLUZONE High-Dose Quadrivalent

    49281-0123-65

    49281-123-65

    197

    6/30/2024

    FLUZONE High-Dose Quadrivalent

    49281-0123-88

    49281-123-88

    197

    6/30/2024

    FLUZONE High-Dose Quadrivalent

    49281-0122-88

    49281-122-88

    197

    6/30/2023

    Fluzone Quad PF 0.5mL

    49281-0423-50

    49281-423-50

    150

    6/30/2024

    Fluzone Quad PF 0.5mL

    49281-0423-88

    49281-423-88

    150

    6/30/2024

    Fluzone Quad MDV

    49281-0639-15

    49281-639-15

    158

    6/30/2024

    Fluzone Quad MDV

    49281-0639-78

    49281-639-78

    158

    6/30/2024

    Fluzone Quad MDV

    49281-0639-15

    49281-639-15

    158

    6/30/2024

    Fluzone Quad MDV

    49281-0639-78

    49281-639-78

    158

    6/30/2024​


    New Code Sets for Hep A, PCV21 and Typhoid.

    3.1 Added New Code sets for Abrysvo, CAPVAXIVE, Harvix and Vivotif.

    Vaccine​

    Tradename

    NDC Code 11 digit

    NDC Code 10 Digit

    Description

    CVX

    MVX

    RSV

    Abrysvo

    00069-2465-01

    0069-2465-01

    1 in 1 CARTON

    305

    PFR

    RSV

    Abrysvo

    00069-2465-10

    0069-2465-10

    10 in 1 CARTON

    305

    PFR

    RSV

    Abrysvo

    00069-2465-19

    0069-2465-19

    .5 mL in 1 VIAL

    305

    PFR

    Hep A - Peds

    Havrix-Peds 2 dose

    50090-3781-00

    50090-3781-0

    10 SYRINGE in 1 CARTON

    83

    SKB

    Hep A - Peds

    Havrix-Peds 2 dose

    50090-3781-01

    50090-3781-1

    .5 mL in 1 SYRINGE

    83

    SKB

    PCV21

    CAPVAXIVE

    00006-4347-01  

    0006-4347-01  

    1 SYRINGE in 1 CARTON

    152

    MSD

    PCV21

    CAPVAXIVE

    00006-4347-02  

    0006-4347-02 

    10 SYRINGE in 1 CARTON

    152

    MSD

    PCV21

    CAPVAXIVE

    00006-4347-99  

    0006-4347-99 

    .5 mL in 1 SYRINGE

    152

    MSD

    Typhoid - Oral

    Vivotif/Ty21a

    50632-0016-02

    50632-016-02

    1 BLISTER PACK in 1 CARTON

    25

    BN

    Typhoid - Oral

    Vivotif/Ty21a

    50632-0016-04

    50632-016-04

    4 CAPSULE, COATED in 1 BLISTER PACK

    25

    BN

    ​ 

    3.2 Added End Dates to Pfizer Comirnaty NDCs.

    Tradename​

    NDC Code 11 digit

    NDC Code 10 Digit

    CVX

    Sale End Date

    Pfizer Comirnaty 12Y+

    00069-2392-01

    0069-2392-01

    309

    6/30/2024

    Pfizer Comirnaty 12Y+

    00069-2392-10

    0069-2392-10

    309

    6/30/2024

    ​ 

    RabAvert Update

    4.1 Associated MVX code BN with CVX code 176 (Tradename RabAvert)
    Assigned the MVX code of BN to NDC 50632-0010-01.
    Assigned the MVX code of BN to NDC 50632-0013-01.
    4.2 Added End Date RabAvert NDC.

    Tradena​me

    NDC Code 11 digit

    NDC Code 10 Digit

    CVX

    Sale End Date

    RabAvert

    50632-0011-01

    50632-011-01

    176

    03/22/2024​


    Historical Entry Update

    5.1​ Updated “Source of Imm” list for Historical entry.
    “Source of Imm” list:

    • Source Unspecified  
    • Other Provider
    • Parent Written Record
    • Parent Recall
    • Other Registry
    • Birth Certificate
    • School Record
    • Public Agency​


    August 21, 2024 (Release 2.8.17)

    ​1. Bug Fixes /Enhancements

    The following fixes appear in this release:​

    Schedule Outlier
    1.1. Updated the following series recommendation to list PCV NOS, the PCV vaccine group default vaccine, when the series is complete.
    ​
    PCV13 Adult
    PCV13 PCV15 Child
    PCV13 PCV15 Late Start 12M
    PCV13 PCV15 Late Start 24M
    PCV13 PCV 15 Late Start 7M
    PCV15 Adult
    PCV20 Adult 1 Dose
     
    1.2. Updated the following series recommendation to list Pneumococcal 23, the vaccine group default vaccine, when the series is complete.
    PPSV23 Adult
    1.3. Added Booster to Japanese Encephalitis schedule.
    1.4. Added Booster to Tick-Borne schedule for Adult.
    1.5. Added Booster to Tick-Borne schedule for Child.
    2. Added the following options when two vaccines are given within a short window from one another using “From CAIR Inventory:” Update, Add Pending and Cancel.
    3. Removed mm values from T-Spot Result screen.

    ​

    July 24, 2024 (Release 2.8.16)

    1. Bug Fixes /Enhancements

    The following fixes appear in this release:​

    ​Data Ex​change​

    • Fixed issue identified where Shot Giver names were not being saved to a dose administered and submitted through Data Exchange. This​ was due to the presence of special characters in the applicable fields when submitted through Data Exchange. The issue contributed to incomplete data on the patient record and the Dose Administered Report. Special characters will be allowed Via DX as they are through the User Interface.
    • Add new Non-US NOS Fractional Inactivated Polio vaccine (fIPV) CVX Code 324 to CAIR. These doses can only be entered as Historical and will not appear in the Trade Name dropdown options.
      • ​Vaccine Group: 20 Polio
      • TRADE NAME: No TRADE NAME
      • Vaccine Name: Fractional dose fIPV NOS Non-US
      • CVX code: 324
      • MVX: UNK
      • NDC: no NDC codes. Vaccine is NOS and Non-US code, so should follow Non-US criteria.
    • ​Added End Dates to MDC Codes for Cholera vaccine Menactra.
    • Inactivate the following NDC codes for Menactra CVX 114 MVX PMC
      • ​​49281-0589-05 (11 digit) 49281-589-05 (10 digit)     End date: 10/01/2022

      • 49281-0589-58 (11 digit) 49281-589-58 (10 digit)     End date: 10/01/2022

     User Interface

    • Removed the mm values in the Panel-A-nil and Panel B-nil dropdown options for TB T-Spot Test results. 
    • Fixed Reminder Recall Report error when using “Use Vaccine Groups Selected.”  An error was reported when a user would select 12 vaccines groups to run the report.
    • Fixed Dose Administered Report to display the 317 Funding under Funding Source and Patient Eligibility columns. After updating CAIR to include the Bridge Funding, these columns displayed blank.​


    June 2, 2024 (Release 2.8.14)

    ​​​1. Bug Fixes /Enhan​cements

    The following fixes appear in this release:​

    ​Data Ex​change

    • ​Added New CVX code 318 NDC Codes for CYFENDUS​
      • Trade Name CYFENDUS attached to CVX 24 CPT 90581 and Vaccine ID 3 need to be cross walked to Anthrax CVX 24 CPT 90581 and Vaccine ID 3 if the date of administration is < 9/19/2023.
      • New CVX Code 318 updated to be assigned to Trade Name CYFENDUS, Vaccine Group Anthrax 03, Vaccine Name Anthrax post-exposure prophylaxis, CVX Code 318, and CPT Code 90581  
      • CYFENDUS NDC’s are 71665-0001-01  - 5 mL in 1 VIAL, MULTI-DOSE and 71665-0001-02 - 10 VIAL, MULTI-DOSE in 1 CARTON. CVX code updated to 318  
      • All IMMs prior to 9/19/2023 with CYFENDUS as vaccine given updated to be assigned Anthrax CVX 24.
      • Disassociated trade name CYFENDUS from CVX 24 and associate the trade name to CVX 318.
      • For CYFENDUS CVX 24 IMMs with the Date of administration
      • 9/19/2023, with NDCs assigned,  belonging to CYFENDUS CVX 318 reassign the IMMs to CYFENDUS CVX 318.​
    • ​Add Unspecified Anthrax Vaccine CVX Code 319.
      • ​​All anthrax CVX codes are associated with vaccine group ANTHRAX. 
      • The following CVX code needs to be added as the NOS for the Anthrax vaccine group. 

        1. ​Add Anthrax vaccine, unspecified to CAIR2 as specified below. 

          CVX ​Code​​

          		 CVX Long Description CVX Short Description CVX Status​
          319
          (NEW​​)           		Anthrax vaccine, unspecified Anthrax vaccine, unspecified Inactive ​


        2. Note th​at unspecified codes ​are added with a status of “Inactive.”  

        3. NOS (Unspecified codes) have no NDCs assigned and are sent as historical doses.

        4. Code to be added to the NOS list for DX processing.

        5. This vaccine, CVX 319 is the new default value for the anthrax vaccine group. 

    Note: Code will not appear on any Trade Name lists and when adding it through the UI user should add it using the Add Historical option and it should be added on the “Add Historical” date grid. 

    User Interface

    • Update to the Immunizations Needed/Routing Slip. Updated the Immunizations Needed/Routing Slip Report to display the patient’s first and last name and be in correct order when the field contains 2 or more values. All of names will now display in the field they belong. The new name order, First Name, Middle Name, Last Nam​e.​​
    • Add Note to Historical Combination Doses. Added a note in red regarding historical combination shots that notifies the user when entering a combination vaccine, it is only necessary to enter a date for one of the antigens. When the Add Details button is clicked and a trade name is selected, the dates will auto-populate for the remaining antigens in the combination.​
    • Changes to Inventory Lot Modification Feature. Relocation the red messages from the bottom of the screens to the top. Changes will appear as follows: 
      1. Edit Vaccine Inventory Information “Inventory was updated successfully.”
      2. Edit Vaccine Inventory Information “Inventory was inserted successfully.” 
      3. Edit Vaccine Inventory Information “Lot already exists with the same Funding Source, inventory has not been added.” 
      4. ​Manage Inventory “Inventory was updated successfully.” 
    • Listed the Modification History regardless of whether a Reason Note was added or not, with the most recent 20 modifications listed automatically and a link for the user to click to view an additional 20 modifications. 
      • The note list displays by most recent date descending and displays details with or without notes.
      • The navigation option at the bottom of the screen brings up the next modification. ​

    • ​Reaction Hyperlink Regular User vs. Power user Roles. Updated the Reaction Red Yes hyperlink to work for Power users as it does for Regular users​​.


    ​​June 13, 2023 (Release 3.8.3.11)

    1. Bug Fixes/Enhanceme​nts

    The following fixes appear in this release:​

    Data Ex​change

    • ​Update RXA-17 Substance Manufacturer Name (CE) 01131 field to display CE data type where |manufacturer code^manufacturer name^MVX| displays.

    • Update RSP for protected clients. RSP returned for patients that do not agree to share, the value returned in QAK-2 was ‘NF,’ meaning Patient Not Found. The value now returned in QAK-2 of the RSP on a protected record will equal ‘PD’ for Protected Data. 

    • RSP increment PID-1 when multiple patients are returned. Update the code in the RSP process to increment the PID-1 by 1 each time a new result is created. Multiple results of the client records will be numbered sequentially.

    • Added CVX  Code 198 Non-US Pentalvalent​

        1. ​Update Vaccine id 801 DTP-Hib-HepB to replaced CVX 102 with 198.
        2. Update all instances of immunizations, and lots with CVX 102 to be 198.​

        3. Add CVX 198 to crosswalk list of non-US vaccines that reject RXA if sent to CAIR as administered vaccine, RXA-9 historical indicator =00.

    User Interface

    • The comment field in the patient information screen has been fixed. The up and down buttons can now be used to view multiple comments associated with the patient.​

    • Added Non-US COVID vaccines COVIDECIA and COMIRNATY. They can only be entered as Historical doses.

    2. ​New Features

    No new features added.​​

    ​​April 12, 2023 (Release 3.8.3.9)

    ​1. Bug Fixes/Enhancements

    The following fixes appear in this release:

    Data Exchange

      • Modified Data E​​​xchange processing to only override the patient’s address when the incoming immunization has a vaccination date more recent than the patient’s existing immunizations.

      • Modifications to the VXU inbound process to no longer set the lock flag on a client that is marked as deceased in the inbound file. Currently the UI does not lock patient records when the client is set to deceased. This change makes the process the same for Data Exchange (DX) and the User Interface (UI).

      • Fix to VXU’​s being sent for COVID vaccines not updating with new CVX code.

      • Added Gamunex-C as a new trade name for the IG vaccine group as well as the NDC code and manufacturer Grifols (GRF)

      • Added Privigen as a new trade name for the IG vaccine group as well as the NDC code and manufacturer CSL Behring (CSL)

    User Interface

      • Added new formulation 1.5 to Vaccine Inventory. It is now included in the dropdown list for entering NDC codes as well as adding or editing vaccine inventory.

    ​2. New Features

    Changes to the Dose Administered Report 

      • Added Administered By column to be populated by the name of the Clinician administering the vaccine

      • Update the Excel spreadsheet to 2 sheets,

        • First sheet to display the Doses Administered Summary

        • Second sheer to display the Doses Administered Details.

      • Changes to the Excel file format allows column manipulation as with the standard excel format.

    Archived Release Notes

    Page Last Updated :